Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Oct 19;17(10):e0275742. doi: 10.1371/journal.pone.0275742

Phytase dose-dependent response of kidney inositol phosphate levels in poultry

Colleen Sprigg 1, Hayley Whitfield 1, Emily Burton 2, Dawn Scholey 2, Michael R Bedford 3, Charles A Brearley 1,*
Editor: Juan J Loor4
PMCID: PMC9581429  PMID: 36260560

Abstract

Phytases, enzymes that degrade phytate present in feedstuffs, are widely added to the diets of monogastric animals. Many studies have correlated phytase addition with improved animal productivity and a subset of these have sought to correlate animal performance with phytase-mediated generation of inositol phosphates in different parts of the gastro-intestinal tract or with release of inositol or of phosphate, the absorbable products of phytate degradation. Remarkably, the effect of dietary phytase on tissue inositol phosphates has not been studied. The objective of this study was to determine effect of phytase supplementation on liver and kidney myo-inositol and myo-inositol phosphates in broiler chickens. For this, methods were developed to measure inositol phosphates in chicken tissues. The study comprised wheat/soy-based diets containing one of three levels of phytase (0, 500 and 6,000 FTU/kg of modified E. coli 6-phytase). Diets were provided to broilers for 21 D and on day 21 digesta were collected from the gizzard and ileum. Liver and kidney tissue were harvested. Myo-inositol and inositol phosphates were measured in diet, digesta, liver and kidney. Gizzard and ileal content inositol was increased progressively, and total inositol phosphates reduced progressively, by phytase supplementation. The predominant higher inositol phosphates detected in tissues, D-and/or L-Ins(3,4,5,6)P4 and Ins(1,3,4,5,6)P5, differed from those (D-and/or L-Ins(1,2,3,4)P4, D-and/or L-Ins(1,2,5,6)P4, Ins(1,2,3,4,6)P5, D-and/or L-Ins(1,2,3,4,5)P5 and D-and/or L-Ins(1,2,4,5,6)P5) generated from phytate (InsP6) degradation by E. coli 6-phytase or endogenous feed phytase, suggesting tissue inositol phosphates are not the result of direct absorption. Kidney inositol phosphates were reduced progressively by phytase supplementation. These data suggest that tissue inositol phosphate concentrations can be influenced by dietary phytase inclusion rate and that such effects are tissue specific, though the consequences for physiology of such changes have yet to be elucidated.

Introduction

The majority of dietary phosphate in animal feed is present as phytate, the mixed metal salt of phytic acid [myo-inositol 1,2,3,4,5,6-hexakisphosphate, InsP6], the primary storage form of phosphate in plant tissues, but a form with reduced availability for digestion by non-ruminant animals [1, 2]. In order to circumvent the need for the addition of inorganic rock phosphate and to reduce costs to the producer and consumer, poultry diets are now often supplemented with microbial phytase [3] with the intention of accessing phytate-bound phosphate as an economical, environmentally sustainable phosphate source.

In addition to providing bioavailable phosphorus from feed, the benefits of the addition of phytases to animal growth performance have been well documented through use of animal feeding trials [4, 5] and include improved feed conversion ratio as well as the reduction in myopathies such as woody breast disorder which reduce meat quality and result in economic losses for farmers [6].

Biochemical measurements, typically of bone or blood parameters, are routinely undertaken alongside bird performance measurements to quantify physiological effects of the addition of phytases to diets [710]. Attention is now being focused on tissues and organs, predominantly by targeted gene expression, e.g., on inositol or phosphate transporters [1114] and signalling pathways [5, 6, 15] or by metabolomics [1618]. Both approaches have been complemented by Western blot of transporters or signalling components in tissues such as intestinal mucosa, liver and muscle [6, 19, 20]. Remarkably, given the importance of inositol phosphates and phosphatidylinositol phosphates to intracellular signalling, the study of effect of phytase has not extended to measurement of these molecules in tissues, except for blood [20].

For feed and digesta, freeze dried and milled samples are typically extracted using sodium fluoride and EDTA solution, pH 10 [11, 21] and InsP3-6 analysed by high performance liquid chromatography (HPLC) with post column complexation with ferric ion and detection by UV at 290 nm. Commonly, inositol is measured by HPLC-pulsed amperometry [9, 11, 2224] by GC [25, 26] or by enzymatic assay [16, 17, 27]. For tissue samples, however, the methods of extraction and analyses are markedly different. Analysis of avian erythrocyte inositol phosphates by acid gradient HPLC has been reported [2830], but for other organs analysis has been limited to myo-inositol [6, 27, 31]. Others have concluded that inositol phosphates are absent from human plasma [32, 33] and similarly for chicken [20], while inositol phosphates have been measured in mouse tissues [34].

In the present study, work up of an HPLC method for tissues has allowed for previously unobtainable measurements of inositol phosphate levels in poultry in response to dietary phytase dosage, beside digesta measurements. It was hypothesised that the known significant impact of phytase supplementation on digesta inositol and inositol phosphates would also extend to tissue inositol phosphate levels.

Therefore, the objectives of this study were to investigate the effects of supplemented phytase on the appearance of inositol phosphates in the gizzard and lower ileum of broilers and on tissue inositol and inositol phosphate levels. The data presented in this study and the treatments discussed are abstracted from a larger 2x4 factorial design study that included an additional treatment of supplemented inositol and two levels of digestibility index marker, not described here. The statistics described here have been applied to the data set published in this study.

Materials and methods

Study diets

This investigation was carried out with 3 treatment diets of 3 levels of phytase (0, 500 and 6000FTU). One basal diet (Table 1) was formulated to contain adequate levels of all nutrients according to the Ross Management Manual 2018. The study was made up of one diet phase–a starter–offered as a mash diet.

Table 1. Ingredient composition and calculated nutrient concentrations of the basal diet.

Ingredient Starter Nutrient Calculated
Wheat 63.12% Crude protein (%) 21.55
Soybean meal1 30.59% Poultry AME kcal/kg 2961.14
Soy oil 2.70% Calcium (%) 0.95
Salt 0.35% Total phosphate (%) 0.73
DL Methionine 0.17% Available phosphate3 (%) 0.45
Lysine HCl 0.12% Phytate P (%) 0.23
Limestone 0.95% Crude fat (%) 4.11
Dicalcium Phosphate 1.50% Poultry ME MJ/kg 12.39
Vitamin premix2 0.50% Poultry NE Kcal/kg 1952.36

148% minimum declared crude protein; sourced from USA.

2Vitamin and Mineral Premix content (per kg diet): Manganese 100 mg, Zinc 88 mg, Iron 20 mg, Copper 10 mg, Iodine 1 mg, Magnesium 0.48 mg, Selenium 0.2 mg, Retinol 13.5 mg, Cholecalciferol 3 mg, Tocopherol 25 mg, Menadione 5.0 mg, Thiamine 3 mg, Riboflavin 10.0 mg, Pantothenic acid 15 mg, Pyroxidine 3.0 mg, Niacin 60 mg, Cobalamin 30 μg, Folic acid 1.5 mg, Biotin 125 μg.

3 Available phosphate (%) does not account for phytate P contribution

The basal diet was divided into 3 equal parts. One part of each lot remained without phytase (Control). The other parts were supplemented with phytase, Quantum Blue, a thermo-tolerant modified E. coli 6-phytase (Quantum Blue, EC 3.1.3.26) supplied by AB Vista (Marlborough, UK). The phytase was added at an intended activity of 500 or 6000 FTU/kg of diet, hereafter Phy500 or Phy6000. The concentrations of inositol and inositol phosphates in each diet were measured by HPLC, and the study diets contained similar concentrations of inositol phosphates (InsPs) (Table 2).

Table 2. Measured inositol and inositol phosphate levels of treatment dietsa.

Diet Inositol InsP3 InsP4 InsP5 InsP6 Σ InsP
Control 80 260 430 1660 18240 20590
Phy500 100 210 430 1540 18520 20700
Phy6000 60 290 750 1460 15980 18480

a Concentrations given as nmol per g dry weight. Control diet 0FTU phytase.

Animals and management

Three levels of phytase (0, Phy500 or Phy6000) were fed in the absence of Ti (TiO2) as an indigestible marker–one aspect of the trial design, to be published separately, was to measure InsP degradation and the effect of dietary Ti inclusion on InsP measurements. The study was performed at Nottingham Trent University (NTU) Poultry Research Unit, School of Animal, Rural and Environmental Sciences, NTU. Institutional and UK national NC3R ARRIVE guidelines for the care, use and reporting of animals in research [35] were followed during the study and all experimental procedures were approved by Nottingham Trent University’s animal ethics review committee (internal code ARE202134). Birds underwent routine vaccination for Marek’s Disease and Infectious Bronchitis (IBH120) at the commercial hatchery.

In the trial as a whole, 480 male Ross 308 broilers were obtained from a commercial hatchery (PD Hook, Cote, Oxford, UK) and randomly allocated to 48 pens as part of a larger study on day 1 (0.8 x 0.8 m), with 10 birds per pen with solid floors covered with wood shavings. Data presented in this study is abstracted from the larger trial set, relating to 3 diet conditions, with 6 replicate pens of 10 birds in each per diet, from which two birds were sampled per pen. The dietary treatments were assigned to the pens (6 pens/treatment) in accordance with a randomized block design in the animal house. Diets were fed from d 1 until slaughter at d 21. Light was provided for 23 hours at placement with 30–40 lux intensity, 1 hour dark, and gradually adjusted to achieve 6 hours of dark by d 7, with 30 minutes of dawn/dusk lighting applied either side of dark period. The temperature of the housing unit was set to 30°C at d 1 and gradually decreased to 21°C over the rearing period. Air quality measurements of carbon dioxide and ammonia levels were monitored, with ammonia not exceeding 25ppm. Diets and water were offered for ad libitum consumption until euthanasia at d 21.

Sampling and analytical methods

After all 10 birds / pen were live-weighed, two birds/pen were randomly selected on day 21 post hatch and euthanized via cervical dislocation without prior stunning by a trained personnel in accordance to the Welfare of Animals at the Time of Killing (England) Regulations [2015] guidelines for poultry. From each euthanized bird, the gizzard was excised and opened so the contents could be gently scraped into a 100 ml container as a pooled sample from both birds, prior to storage at -20°C prior to freeze-drying. For ileal digesta collection, digesta from the same two birds was collected by gentle digital pressure into one pot and stored at -20°C prior to freeze-drying. Once freeze-dried, the samples were finely ground with a pestle and mortar. The ground samples were stored at 4°C until analysis. Diets, gizzard and ileal digesta were extracted as described in Whitfield et al. [20].

For tissue analysis, from each of the two birds from which digesta was pooled for analysis, brain, kidney, liver and leg/breast muscle samples were excised, taking care to ensure tissue was consistently excised from the same region of organ or muscle for each bird. For each tissue type collected, the samples of both birds were pooled and stored in polythene bags and immediately frozen at -20°C before shipping to UEA for inositol phosphate and inositol analysis. Samples were stored thereafter at -80°C. After defrosting, 100 mg slices of tissue were taken for InsP extraction and analysis.

For inositol phosphate analysis, 100 mg (frozen weight) of kidney tissue was homogenised by Ultra-Turrax (IKA T-10 Ultra-Turrax® High-Speed Homogeniser) in 600 μL: 1M HClO4 on ice and transferred to a 1.5 mL tube. Samples were kept on ice for 20 minutes with vortex mixing every 10 minutes and centrifuged at 13,000 x g for 10 minutes at 4°C. The resulting cleared lysate was transferred to a clean 1.5 mL tube, and 20 μL of which was taken and diluted to 1000 μL with 18.2 Megohm.cm water for inositol analysis.

The following extraction method is adapted from Wilson et al. [32]. All steps were carried out at 4°C for the prevention of acid degradation of inositol phosphates. Prior to extraction, titanium dioxide (TiO2) beads (Titansphere® TiO2 5 μM, Hichrom) were washed in 1M HClO4. Then, to each cleared lysate, 5 mg of Titansphere® TiO2 beads in 50 μL HClO4 was added. Samples were vortexed briefly and extracted for 30 minutes with mixing on a rotator. Samples were centrifuged at 3500 x g for 5 minutes to pellet the TiO2 beads and the HClO4 supernatant discarded.

In order to elute the bound inositol phosphates, the TiO2 beads were resuspended in 200 μL 3% ammonium hydroxide solution (pH 10) vortexed and incubated with rotation for 5 minutes at 4°C. Samples were centrifuged at 3500 x g for 1 minute and supernatant containing the inositol phosphates were transferred to a clean 1.5 mL tube. A further 200 μL elution in fresh 3% ammonium hydroxide was carried out and the supernatants pooled. Samples were vacuum evaporated until dry and resuspended in 100 μL of 18.2MOhm.cm water for further analysis by HPLC or stored at -20°C prior to downstream analysis.

50 μL samples were analysed by high-performance liquid chromatography and UV detection at 290 nm after post column reaction with ferric ion, on a 250 x 3 mm Thermo Scientific™ Dionex™ CarboPac™ PA200 column (Dionex™) with a corresponding 3 x 50 mm guard column of the same material. The column was eluted at a flow rate of 0.4 mL/min with an increasing gradient of methanesulfonic acid, derived from buffer reservoirs containing (A) water and (B) 0.6M methanesulfonic acid, by mixing according to the following schedule: time (minutes), %B; 0, 0; 25, 100; 38, 100 [36]. Fe[NO3)3 in 2% HClO4 was used as the post-column reagent [37] added at a flow rate of 0.2 mL/min. The elution order of InsPs was established using acid-hydrolysed InsP6 standards. Concentration of InsPs was established by reference to UV detector response to injection of InsP6 (Merck).

For inositol analysis, samples extracted as above were diluted 50-fold in 18.2MOhm.cm water. Inositol was determined by HPLC pulsed amperometry of 20 μL aliquots after separation by 2-dimensional HPLC on Dionex CarboPac PA1 and MA1 columns [38].

Statistical analysis

Inositol, inositol phosphates and total inositol phosphates for data sets presented in this report were compared by multiple T tests with correction for multiple comparisons using the Holm-Šídák method using GraphPad Prism, version 7.0e, for Mac OS X (GraphPad Software, La Jolla, CA). The level of significance for all tests was set at P < 0.05. Adjusted P values following T tests are presented in the tables for each data set.

Results

Phytate (InsP6) hydrolysis in gizzard and ileal digesta

Supplementation of diet with Phy500 and Phy6000 reduced total inositol phosphates significantly (P = 0.037 and P<0.0001, respectively) in gizzard contents (Table 3), with reductions in InsP6 and total InsPs increasing with increasing phytase dose. Total inositol phosphate levels were reduced from 14852 ± 817 nmol/g dwt (dry weight) in the Control group to 8608 (±1756) nmol/g dwt at Phy500 and to 1029 ± 183 nmol/g dwt at Phy6000. Phytase at 500 FTU/kg reduced InsP5 and InsP6 significantly (P = 0.001 and P = 0.018, respectively), from 4721 ± 440 nmol/g dwt and 6872 ± 995 nmol/g dwt, respectively, to 1121 ± 419 and 1645 ± 905 nmol/g dwt. The “super dosed” group at Phy6000 also showed highly significant reductions (both P<0.001) in InsP5 (96 ± 61 nmol/ g dwt) and InsP6 (142 ± 57 nmol/g dwt).

Table 3. Inositol and inositol phosphate (InsP2-6) levels (nmol/g dwt) in gizzard digesta of day 21 broilers1,2.

Diet Inositol InsP2 InsP3 InsP4 InsP5 InsP6 Σ InsP
Control 348±77 193±42 590±137 2473±484 4721±440 6872±995 14852±817
Phy500 900±147 677±139 1777±728 3387±1353 1121±419 1645±905 8608±1756
Phy6000 2606±326 74±22 417±165 298±81 96±61 142±57 1029±183
Probabilities
Control vs. Phy500 0.037 0.037 0.261 0.8539 0.001 0.018 0.037
Control vs. Phy6000 0.0002 0.065 0.439 0.003 <0.0001 0.0002 <0.0001
Phy500 vs. Phy6000 0.005 0.009 0.187 0.137 0.137 0.187 0.009

Abbreviations: Σ InsP, total InsP2 to InsP6; InsP6, inositol hexakisphosphate; InsP5, inositol pentakisphosphate; InsP4, inositol tetrakisphosphate; InsP3, inositol trisphosphate; InsP2, inositol bisphosphate.

1The control group was fed with a diet with 0.45% calculated available phosphate. Groups Phy500 and Phy6000 were fed with the control diet supplemented with 500 or 6,000 FTU of phytase per kilogram of feed, respectively.

2Data are given as group means ± SEM, n = 6, of 6 replicate pens with samples pooled from 2 broilers per pen per treatment. Statistical analysis was performed by multiple T tests with correction for multiple comparisons using the Holm-Šídák method for inositol, inositol phosphate and Σ InsP data.

Total inositol phosphate levels were reduced significantly from 61346 ± 3702 nmol/g dwt in ileal contents for the Control group to 40410 ± 3921 nmol/g dwt at Phy500 (P = 0.018) and to 10173 ± 2236 nmol/g dwt at Phy6000 (P<0.0001) (Table 4), with similar reduction compared to gizzard digesta response to phytase. Effects on InsP6 levels were highly significant at both Phy500 and Phy6000 (for Phy500, P = 0.008; for Phy6000, P<0.0001). Here, InsP6 was reduced from 51587 ± 3269 nmol/g dwt, for Control group, to 29190 ± 3803 nmol/g dwt and 1747 ± 385 nmol/g dwt, respectively.

Table 4. Inositol and inositol phosphate (InsP2-6) levels (nmol/g dwt) in ileal digesta of day 21 broilers1,2.

Diet Inositol InsP2 InsP3 InsP4 InsP5 InsP6 Σ InsP
Control 1008±297 502±131 1358±155 2613±306 5285±519 51587±3269 61346±3702
Phy500 2434±654 1349±173 3401±548 7037±2014 6198±682 29190±3803 40410±3921
Phy6000 10870±2233 2535±659 1613±357 3843±1172 432±96 1747±385 10173±2236
Probabilities
Control vs. Phy500 0.102 0.018 0.028 0.107 0.311 0.008 0.018
Control vs. Phy6000 0.004 0.038 0.557 0.557 0.0001 <0.0001 <0.0001
Phy500 vs. Phy6000 0.018 0.212 0.076 0.212 <0.0001 0.0001 0.0002

Abbreviations: Σ InsP, total InsP2 to InsP6; InsP6, inositol hexakisphosphate; InsP5, inositol pentakisphosphate; InsP4, inositol tetrakisphosphate; InsP3, inositol trisphosphate; InsP2, inositol bisphosphate.

1The control group was fed with a diet with 0.45% calculated available phosphate. Groups Phy500 and Phy6000 were fed with the control diet supplemented with 500 or 6,000 FTU of phytase per kilogram of feed, respectively.

2Data are given as group means ± SEM, n = 6, of 6 replicate pens with samples pooled from 2 broilers per pen per treatment. Statistical analysis was performed by multiple T tests with correction for multiple comparisons using the Holm-Šídák method for inositol, inositol phosphate and Σ InsP data.

Inositol levels of the gizzard and ileal contents were both impacted by inclusion of phytase in the diet (Tables 3 and 4), with increases in detectable free inositol with increasing phytase dose. Highly significant differences in inositol were measured at Phy6000 in both the gizzard and ileum (for the gizzard, P = 0.0002; for the ileum, P = 0.004). At Phy500, effects were significant in the gizzard but not in the ileum (P = 0.037 for gizzard and P = 0.102 for ileum). Inositol levels were measured at 348 ± 77 nmol/g dwt in the gizzard digesta for the Control group, 900 ± 147 nmol/g dwt at Phy500 and 2606 ± 284 nmol/g dwt at Phy6000. Inositol levels of the ileal contents were 1008 ± 297 nmol/g dwt for the Control group, compared with 2434 ± 654 nmol/g dwt for the Phy500 and 10870 ± 2233 nmol/g dwt for the Phy6000 groups. The observed greater effect on total inositol phosphates in the gizzard as opposed to the ileal digesta has been observed previously, and in these studies in which non-digestible markers have been used the effect may arise from the faster transit of soluble InsPs through the gizzard in comparison to the digestibility index marker and therefore subsequent apparent concentration in the terminal ileum.

Profiles of tissue inositol phosphates

One objective of this study was to investigate the effect of the addition of dietary phytase on the inositol phosphate levels observed in poultry tissues. Previous studies have identified changes in plasma inositol levels in relation to changes in gizzard and ileal phytate hydrolysis [9, 20, 27], but have been unable to access tissue inositol phosphates by commonly used analytical methods. Consequently, the inositol phosphate profile of different tissues is undefined. Here, the use of TiO2 beads to pre-concentrate inositol phosphates during extraction enabled us in this study to measure inositol phosphate levels in combination with existing analytical methods.

Kidney tissue inositol phosphates (Table 5) show similar reduction as in digesta with increasing phytase. Ins(1,3,4,5,6)P5 is the dominant inositol phosphate measured in these tissues followed by D-/and or L-Ins(3,4,5,6)P4, with InsP5 over 3-fold higher than InsP6 in these samples (Fig 1B). Significant differences were measured between the Control and Phy6000 diets for: InsP4 (P = 0.023), 27.0 ± 5.4 nmol/g wwt and 9.8 ± 1.5 nmol/g wwt, respectively; InsP5 (P = 0.006), 40.7.0 ± 6.0 nmol/g wwt and 15.9 ± 3.1 nmol/g wwt, respectively; InsP6 (P = 0.003), 15.4 ± 2.4 mnol/g wwt and 5.2 ± 0.73 nmol/g wwt, respectively. At Phy500, InsP4, 14.0 ± 2.1 nmol/g wwt and InsP5, 31.5 ± 3.0 nmol/g wwt were not statistically significantly different (P = 0.0592 and P = 0.2762, respectively).

Table 5. Inositol and inositol phosphate (InsP2-6) levels (nmol/g wwt) in kidney of day 21 broilers1,2.

Diet Inositol InsP2 InsP3 InsP4 InsP5 InsP6 Σ InsP
Control 6430±480 1.4±0.2 3.3±1.0 27.0±5.4 40.7±6.0 15.4±2.4 87.9±12.5
Phy500 6600±260 0.9±0.2 1.2±0.1 14.0±2.1 31.5±3.0 10.6±2.1 58.1±5.5
Phy6000 7530±310 0.7±0.2 1.7±0.6 9.8±1.5 15.9±3.1 5.2±0.73 33.4±5.1
Probabilities
Control vs. Phy500 0.770 0.182 0.203 0.203 0.366 0.366 0.203
Control vs. Phy6000 0.134 0.039 0.182 0.023 0.006 0.003 0.003
Phy500 vs. Phy6000 0.130 0.611 0.570 0.317 0.013 0.120 0.019

Abbreviations: Σ InsP, total InsP2 to InsP6; InsP6, inositol hexakisphosphate; InsP5, inositol pentakisphosphate; InsP4, inositol tetrakisphosphate; InsP3, inositol trisphosphate; InsP2, inositol bisphosphate.

1The control group was fed with a diet with 0.45% calculated available phosphate. Groups Phy500 and Phy6000 were fed with the control diet supplemented with 500 or 6,000 FTU of phytase per kilogram of feed, respectively.

2Data are given as group means ± SEM, n = 12, of 6 replicate pens with samples taken from 2 broilers per pen per treatment. Statistical analysis was performed by multiple T tests with correction for multiple comparisons using the Holm-Šídák method for inositol, inositol phosphate and Σ InsP data.

Fig 1. Inositol phosphates in broiler digesta and tissue.

Fig 1

Extracts of (A), liver; (B), kidney; (D), gizzard contents; (E), ileal contents; from a single bird (A,B) or pooled from 2 birds (D,E) fed the Control diet were analysed by HPLC. (C) and (F), standards run beside the different sample sets from which A,B and D,E, respectively, were obtained. Inositol phosphate classes and individual isomers are identified.

Total inositol phosphate levels were reduced significantly (P = 0.003) in the kidney from a Control value of 87.9 ± 12.5 nmol/g wwt, to 33.4 ± 5.1 nmol/g wwt at Phy6000 (Table 5).

Ins(1,3,4,5,6)P5 was the dominant inositol phosphate in liver (Table 6, Fig 1A), and although in this case InsP6 was the next most abundant species, the identities of inositol phosphates were similar to kidney. Liver inositol phosphate levels showed a reduction in inositol phosphates from 36.5 ± 5.3 nmol/g wwt for the Control group to 24.3 ± 3.4 nmol/g wwt on addition of Phy500, though further reduction with increasing, Phy6000, was not observed, 30.8 ± 5.7 nmol/g wwt, and neither treatment was significantly different from Control group (for Phy500, P = 0.327; for Phy6000, P = 0.927).

Table 6. Inositol and inositol phosphate (InsP2-6) levels (nmol/g wwt) in liver of day 21 broilers1,2.

Diet Inositol InsP2 InsP3 InsP4 InsP5 InsP6 Σ InsP
Control 15920±870 n.d. 2.2±0.1 1.8±0.3 23.6±4.3 8.9±1.4 36.5±5.3
Phy500 16060±550 n.d. 2.3±0.4 1.3±0.3 15.1±2.2 5.5±1.1 24.3±3.4
Phy6000 18110±990 n.d. 2.0±0.2 1.7±0.3 19.4±4.6 7.7±1.1 30.8±5.7
Probabilities
Control vs. Phy500 0.964 - 0.964 0.481 0.328 0.328 0.328
Control vs. Phy6000 0.507 - 0.927 0.927 0.927 0.927 0.927
Phy500 vs. Phy6000 0.408 - 0.808 0.808 0.808 0.601 0.808

Abbreviations: Σ InsP, total InsP2 to InsP6; InsP6, inositol hexakisphosphate; InsP5, inositol pentakisphosphate; InsP4, inositol tetrakisphosphate; InsP3, inositol trisphosphate; InsP2, inositol bisphosphate.

1The control group was fed with a diet with 0.45% calculated available phosphate. Groups Phy500 and Phy6000 were fed with the control diet supplemented with 500 or 6,000 FTU of phytase per kilogram of feed, respectively.

Kidney inositol levels were not significantly affected by the addition of phytase to the control diet despite changes to inositol phosphate levels observed in the same sample (Table 5). Slight numerical increases in the inositol levels were measured in the kidney tissue between different dietary phytase doses, with 6430 ± 480 nmol/g wwt in the Control group; 6600 ± 260 nmol/g wwt with Phy500 and 7530 ± 310 nmol/g wwt with Phy6000. The differences were not significant (Control vs. Phy500, P = 0.182; Control vs. Phy6000, P = 0.133).

Similarly, sample inositol levels were increased in the liver tissue from 15920 ± 870 nmol/g wwt in the Control group to 16060 ± 550 nmol/g wwt at Phy500, and 18110 ± 990 nmol/g wwt at Phy6000, but again these differences were not significant (Control vs. Phy500, P = 0.964; Control vs. Phy6000, P = 0.507) (Table 6). In the study of Gonzalez-Uarquin et al. [31], a statistically significant increase in tissue inositol was observed in kidney of d 21 broilers at 1500 FTU/kg, but not at 3000 FTU/kg, while liver levels of inositol did not differ between treatments.

Inositol phosphates in avian tissues

The peaks identified in Fig 1B for kidney tissue samples are also the isomers present in liver tissue samples (Fig 1A). The identities of peaks in the set of standards (Fig 1C) have been described [20, 36, 39]. The isomers detected in tissues, D-and/or L-Ins(3,4,5,6)P4 and Ins(1,3,4,5,6)P5, differ from the known products of phytate degradation in Quantum Blue-supplemented diets, D-and/or L-Ins(1,2,3,4)P4, D-and/or L-Ins(1,2,5,6)P4, Ins(1,2,3,4,6)P5, D-and/or L-Ins(1,2,3,4,5)P5 and D-and/or L-Ins(1,2,4,5,6)P5 [40] (Fig 1D and 1E). We comment that the diets were fed as mash without heat treatment, hence the presence of Ins(1,2,3,4,6)P5, a known product of endogenous phytase in wheat-based diets not exposed to heat via pelleting.

Discussion

The tissue inositol phosphates (Fig 1A and 1B) are similar to those identified in avian erythrocytes [20, 41, 42]. Thus, despite clear impact of dietary phytase on inositol phosphates in gizzard and ileal content, and on tissue inositol phosphates, the tissue isomers (of inositol phosphates) are phosphorylated in positions not expected from phytate degradation by Quantum Blue or endogenous feed phytase. Rather, they reflect the isomers expected from de novo inositol phosphate synthesis [42] and they match the isomers analysed in Xenopus and rat skeletal muscles [41]. It is widely accepted that products of phytate degradation retain phosphate in the 2-position. It is also widely accepted that the final step in inositol hexakisphosphate biosynthesis involves addition of phosphate to the 2-position [33]. Because the isomers observed in tissues lacked the 2-phosphate, they cannot arise simply by absorption from the gut, since those in the gut possess the 2-phosphate. While it cannot be excluded that potential selective InsP absorption and metabolism thereof contributes to the tissue profile observed, inositol phosphate transporters have not been described in animals. In contrast there are a plethora of studies describing expression profiles and biochemical properties of inositol and phosphate transporters in the gastro-intestinal tract of poultry. We conclude that the effect seen in different dietary conditions (0, Phy500, and Phy6000) does not arise from uptake of InsPs following gut phytate hydrolysis, but rather from tissue response to changing phosphate and/or inositol availability.

Kidney tissue inositol phosphate levels, as individual InsP4, InsP5 and InsP6 isomer(s), as well as total inositol phosphate levels, decrease with increasing phytase dose. This suggests that the response arises from the influence of increasing free inorganic Pi and/or inositol in the gut and/or their tissue-specific influence on inositol phosphate biosynthetic gene expression. We are not aware of any studies of tissue response of inositol phosphates to circulatory inositol or phosphate, other than in blood [20]. Nonetheless, increases in circulatory inositol with dietary phytase are widely reported in poultry [9, 16, 17, 2327].

In animals and humans, the kidney is the most important organ for maintenance of inositol concentration regulation in blood plasma [43], and studies in rat models suggest inositol catabolism occurs mainly in the kidney [44], though there is no research to suggest that the same models hold true for poultry tissues [27]. Likewise, there is no current consensus where the aggregate mass of inositol phosphate synthesis occurs or how circulatory inositol modifies tissue inositol synthesis and use. Nevertheless, as inositol and phosphate are the absorbable co-products of phytase action, it seems likely that the physiological response of poultry to phytase integrates the two. Response of poultry to phytase is most commonly interpreted in context of Ca and available phosphate with particular focus on amino acid digestibility and Ca: P [4, 26]. It is relevant, therefore, to put inositol provision in context of Ca and phosphate homeostasis. This study shows that in broilers kidney inositol phosphate levels are particularly responsive to dietary phytase, while liver levels are not.

Human and mammalian studies show that inter-organ signalling between the gut, kidney, Parathyroid gland (PTG) and bone, mediated by hormones, vitamin D, parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), regulates phosphate homeostasis [4548], with studies using mice models showing Na/Pi cotransporters in the small intestine and kidney are regulated by dietary phosphate [49]. Circulatory phosphate is controlled tightly and tissue phosphate is protected by phosphate resorption from bone under control of PTH: under conditions of hypocalcaemia the PTG increases PTH secretion, which decreases renal distal tubule calcium excretion and inhibits phosphate reabsorption in the proximal tubule [48]. In conditions of hyperphosphataemia, FGF23 produced by osteoblasts and osteocytes in response to PTH increases renal phosphate excretion by down-regulating the expression of NaPi-IIa and NaPiIIc cotransporters in the proximal tubules. Antibodies against FGF23 have been show to increase P retention in poultry [50].

In chickens, plasma vitamin D is predominantly 25-OH-D3 with lower levels of 24,25-(OH)2-D3 [51]: the liver is the principal organ modifying cholecalciferol (vitamin D3) by hydroxylation to 25-OH-D3, the most active form in poultry [52], while further conversion (and inactivation) to 24,25-(OH)2-D3 by 24-OHase is mediated by an enzyme with highest expression in chicken kidney [53]. 1α-OH-D3 supplementation of broiler diets is purported to bypass the critical 1-hydroxylation of 25-OH-D3 occurring in the kidney, by allowing 25-OHase of the liver to produce the vitamin D receptor- (VDR-) active ligand 1,25-(OH)2-D3 [54].

Vitamin D (D3 predominantly) has been studied most extensively in poultry as additive to diet in context of tibial dyschondroplasia or egg production and there are relatively few reports of vitamin D or its metabolite levels in plasma or tissues of supplemented or non-supplemented birds [54, 55]. We are not aware of studies of effect of phytase on levels of vit D or its metabolites, though, we note synergistic effect of phytase and vit D3 on growth performance, interpreted, in part, in context of effect of vit D3 on intestinal phytase activity [56]. Earlier reports point to the efficacy of vit D3 and its derivatives to increase phytate hydrolysis [5759].

In laying hens, medullary bone is a highly labile source of calcium and phosphate for production of eggshell [60, 61]. The high calcium requirement of layers [12] will likely add further complication, beyond that elaborated here for broilers, to the intersection of the inositol and phosphate co-products (of phytase action) with phosphate homeostasis. Nevertheless, Greene et al. [15] have shown that the mRNA levels of various genes of inositol phosphate synthesis and turnover, inositol polyphosphate 1-phosphatase (INPP1), inositol hexakisphosphate kinase 1–2 (IP6K1-3), myo-inositol phosphate synthase (ISYNA) and multiple inositol polyphosphate phosphatase (MINPP1) are altered post-prandially in blood and feather of broilers by phytase. One implication is that tissue inositol phosphate synthesis/turnover is responsive to phytase, as recently shown for blood [20]. While some studies ascribe cellular function to the IP6K1-3/InsP6 product, 5-InsP7, as regulator of plasma phosphate [62], evidence from this poultry trial suggests that physiologically the kidney is especially responsive, directly or indirectly, to phosphate and/or inositol from diet. The methods elaborated here, in their use of TiO2 as a pre-concentration method for inositol phosphate analysis, will allow incisive testing of tissue inositol phosphate contribution to phosphate homeostasis by allowing simple experimental access to previously unobtainable inositol phosphate measurements.

Supporting information

S1 Data

(ZIP)

Acknowledgments

We thank the Science Analytical Facilities, Faculty of Science, UEA for technical assistance.

Conflict of interests statement: AB Vista had no role in conducting the research, generating the data, interpreting the results or writing the manuscript.

Data Availability

All relevant data are within the paper and its Supporting Information files. Any question pertaining to the data underlying the results presented in the study can be addressed to Charles Brearley, University of East Anglia.

Funding Statement

This study was funded by award of a BBSRC Norwich Research Park Doctoral Training Studentship (Ref. BB/M011216/1) to C.S. with contribution from AB Vista. https://biodtp.norwichresearchpark.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Lucca W, Shirmann GD, Figueiredo AM, Zanella I, De Oliveira V. Endogenous losses and true digestibility of phosphorus in rice bran with or without phytase determined with piglets. Ciência Rural. 2016;46(6):1082–7. [Google Scholar]
  • 2.Maenz DD, Classen HL. Phytase Activity in the Small Intestinal Brush Border Membrane of the Chicken. Poult Sci. 1998;77(4):557–63. doi: 10.1093/ps/77.4.557 [DOI] [PubMed] [Google Scholar]
  • 3.Selle PH, Ravindran V. Microbial phytase in poultry nutrition. Anim Feed Sci Technol. 2007;135(1–2):1–41. [Google Scholar]
  • 4.Cowieson AJ, Ruckebusch JP, Sorbara JOB, Wilson JW, Guggenbuhl P, Roos FF. A systematic view on the effect of phytase on ileal amino acid digestibility in broilers. Anim Feed Sci Technol. 2017;225(February):182–94. [Google Scholar]
  • 5.Schmeisser J, Séon AA, Aureli R, Friedel A, Guggenbuhl P, Duval S, et al. Exploratory transcriptomic analysis in muscle tissue of broilers fed a phytase-supplemented diet. J Anim Physiol Anim Nutr (Berl). 2017;101(3):563–75. doi: 10.1111/jpn.12482 [DOI] [PubMed] [Google Scholar]
  • 6.Greene E, Flees J, Dadgar S, Mallmann B, Orlowski S, Dhamad A, et al. Quantum Blue reduces the severity of Woody Breast Myopathy via modulation of oxygen homeostasis-related genes in broiler chickens. Front Physiol. 2019;10(October):1–21. doi: 10.3389/fphys.2019.01251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cowieson AJ, Ptak A, Maćkowiak P, Sassek M, Pruszyńska-Oszmałek E, Zyła K, et al. The effect of microbial phytase and myo-inositol on performance and blood biochemistry of broiler chickens fed wheat/corn-based diets. Poult Sci. 2013;92(8):2124–34. [DOI] [PubMed] [Google Scholar]
  • 8.Cowieson AJ, Roos FF, Ruckebusch JP, Wilson JW, Guggenbuhl P, Lu H, et al. Time-series responses of swine plasma metabolites to ingestion of diets containing myo-inositol or phytase. Br J Nutr. 2017;118(11):897–905. [DOI] [PubMed] [Google Scholar]
  • 9.Pirgozliev V, Brearley CA, Rose SP, Mansbridge SC. Manipulation of plasma myo-inositol in broiler chickens: effect on growth performance, dietary energy, nutrient availability and hepatic function. Poult Sci. 2019;98(1):260–8. [DOI] [PubMed] [Google Scholar]
  • 10.Zyła K, Grabacka M, Pierzchalska M, Duliński R, Starzyńska-Janiszewska A. Effect of inositol and phytases on hematological indices and α-1 acid glycoprotein levels in laying hens fed phosphorus-deficient corn-soybean meal-based diets. Poult Sci. 2013;92(1):199–204. doi: 10.3382/ps.2012-02651 [DOI] [PubMed] [Google Scholar]
  • 11.Walk CL, Bedford MR, Olukosi OA. Effect of phytase on growth performance, phytate degradation and gene expression of myo-inositol transporters in the small intestine, liver and kidney of 21 day old broilers. Poult Sci. 2018;97(4):1155–62. doi: 10.3382/ps/pex392 [DOI] [PubMed] [Google Scholar]
  • 12.Sommerfeld V, Huber K, Bennewitz J, Camarinha-Silva A, Hasselmann M, Ponsuksili S, et al. Phytate degradation, myo-inositol release, and utilization of phosphorus and calcium by two strains of laying hens in five production periods. Poult Sci. 2020;99(12):6797–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hu Y, Liao X, Wen Q, Lu L, Zhang L, Luo X. Phosphorus absorption and gene expression levels of related transporters in the small intestine of broilers. Br J Nutr. 2018;119(12):1346–54. doi: 10.1017/S0007114518000934 [DOI] [PubMed] [Google Scholar]
  • 14.Zanu HK, Kheravii SK, Morgan NK, Bedford MR, Swick RA. Interactive effect of dietary calcium and phytase on broilers challenged with subclinical necrotic enteritis: part 2. Gut permeability, phytate ester concentrations, jejunal gene expression, and intestinal morphology. Poult Sci. 2020;99(10):4914–28. doi: 10.1016/j.psj.2020.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Greene E, Mallmann B, Wilson JW, Cowieson AJ, Dridi S. Monitoring phytate hydrolysis using serial blood sampling and feather myo-inositol levels in broilers. Front Physiol. 2020;11(June):1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gonzalez-Uarquin F, Sommerfeld V, Rodehutscord M, Huber K. Interrelationship of myo-inositol pathways with systemic metabolic conditions in two strains of high-performance laying hens during their productive life span. Sci Rep. 2021;11(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gonzalez-Uarquin F, Kenéz, Rodehutscord M, Huber K. Dietary phytase and myo-inositol supplementation are associated with distinct plasma metabolome profile in broiler chickens. Animal. 2020;14(3):549–59. doi: 10.1017/S1751731119002337 [DOI] [PubMed] [Google Scholar]
  • 18.Greene E, Cauble R, Dhamad AE, Kidd MT, Kong B, Howard SM, et al. Muscle metabolome profiles in Woody Breast-(un)affected broilers: Effects of Quantum Blue phytase-enriched diet. Front Vet Sci. 2020;7(August):1–15. doi: 10.3389/fvets.2020.00458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huber K, Zeller E, Rodehutscord M. Modulation of small intestinal phosphate transporter by dietary supplements of mineral phosphorus and phytase in broilers. Poult Sci. 2015;94(5):1009–17. doi: 10.3382/ps/pev065 [DOI] [PubMed] [Google Scholar]
  • 20.Whitfield H, Laurendon C, Rochell S, Dridi S, Lee S, Dale T, et al. Effect of phytase supplementation on plasma and organ myo-inositol content and erythrocyte inositol phosphate in chickens. J Appl Anim Nutr. 2022;In press. [Google Scholar]
  • 21.Zeller E, Schollenberger M, Witzig M, Shastak Y, Kühn I, Hoelzle LE, et al. Interactions between supplemented mineral phosphorus and phytase on phytate hydrolysis and inositol phosphates in the small intestine of broilers. Poult Sci. 2015;94(5):1018–29. [DOI] [PubMed] [Google Scholar]
  • 22.Laird S, Kühn I, Wilcock P, Miller HM. The effects of phytase on grower pig growth performance and ileal inositol phosphate degradation. J Anim Sci. 2016;94(7):142–5. [Google Scholar]
  • 23.Kriseldi R, Walk CL, Bedford MR, Dozier WA. Inositol and gradient phytase supplementation in broiler diets during a 6-week production period: 2. Effects on phytate degradation and inositol liberation in gizzard and ileal digesta contents. Poult Sci. 2021;100(3):100899. doi: 10.1016/j.psj.2020.11.068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Walk CL, Santos TT, Bedford MR. Influence of superdoses of a novel microbial phytase on growth performance, tibia ash, and gizzard phytate and inositol in young broilers. Poult Sci. 2014;93(5):1172–7. doi: 10.3382/ps.2013-03571 [DOI] [PubMed] [Google Scholar]
  • 25.Ajuwon KM, Sommerfeld V, Paul V, Däuber M, Schollenberger M, Kühn I, et al. Phytase dosing affects phytate degradation and Muc2 transporter gene expression in broiler starters. Poult Sci. 2020;99(2):981–91. doi: 10.1016/j.psj.2019.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sommerfeld V, Schollenberger M, Kühn I, Rodehutscord M. Interactive effects of phosphorus, calcium, and phytase supplements on products of phytate degradation in the digestive tract of broiler chickens. Poult Sci. 2018;97(4):1177–88. doi: 10.3382/ps/pex404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gonzalez-Uarquin F, Rodehutscord M, Huber K. Myo-inositol: its metabolism and potential implications for poultry nutrition—a review. Poult Sci. 2020;99(2):893–905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Casals I, Villar JL, Riera-Codina M. A straightforward method for analysis of highly phosphorylated inositols in blood cells by high-performance liquid chromatography. Anal Biochem. 2002;300(1):69–76. doi: 10.1006/abio.2001.5449 [DOI] [PubMed] [Google Scholar]
  • 29.Mayr GW. A novel metal-dye detection system permits picomolar-range h.p.l.c. analysis of inositol polyphosphates from non-radioactively labelled cell or tissue specimens. Biochem J. 1988;254(2):585–91. doi: 10.1042/bj2540585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Whitfield H, White G, Sprigg C, Riley AM, Potter BVL, Hemmings AM, et al. An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels. Biochem J. 2020;477(14):2621–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gonzalez-Uarquin F, Molano E, Heinrich F, Sommerfeld V, Rodehutscord M, Huber K. Research Note: Jejunum phosphatases and systemic myo-inositol in broiler chickens fed without or with supplemented phytase. Poult Sci. 2020;99(11):5972–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wilson MSC, Bulley SJ, Pisani F, Irvine RF, Saiardi A. A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine. Open Biol. 2015. Mar;5(3):150014. doi: 10.1098/rsob.150014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Letcher AJ, Schell MJ, Irvine RF. Do mammals make all their own inositol hexakisphosphate? Biochem J. 2008;416(2):263–70. doi: 10.1042/BJ20081417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Qiu D, Wilson MS, Eisenbeis VB, Harmel RK, Riemer E, Haas TM, et al. Analysis of inositol phosphate metabolism by capillary electrophoresis electrospray ionization mass spectrometry. Nat Commun. 2020;11(1):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol. 2010;160(7):1577–9. doi: 10.1111/j.1476-5381.2010.00872.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Whitfield H, Riley AM, Diogenous S, Godage HY, Potter BVL, Brearley CA. Simple synthesis of 32P-labelled inositol hexakisphosphates for study of phosphate transformations. Plant Soil. 2018. Jun 27;427(1–2):149–61. doi: 10.1007/s11104-017-3315-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Phillippy BQ, Bland JM. Gradient ion chromatography of inositol phosphates. Anal Biochem. 1988;175(1):162–6. doi: 10.1016/0003-2697(88)90374-0 [DOI] [PubMed] [Google Scholar]
  • 38.Lee SA, Dunne J, Febery E, Brearley CA, Mottram T, Bedford MR. Exogenous phytase and xylanase exhibit opposing effects on real-time gizzard pH in broiler chickens. Br Poult Sci. 2018;59(5):568–78. doi: 10.1080/00071668.2018.1496403 [DOI] [PubMed] [Google Scholar]
  • 39.Rix GD, Todd JD, Neal AL, Brearley CA. Improved sensitivity, accuracy and prediction provided by a high-performance liquid chromatography screen for the isolation of phytase-harbouring organisms from environmental samples. Microb Biotechnol. 2021;14(4):1409–21. doi: 10.1111/1751-7915.13733 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sommerfeld V, Künzel S, Schollenberger M, Kühn I, Rodehutscord M. Influence of phytase or myo-inositol supplements on performance and phytate degradation products in the crop, ileum, and blood of broiler chickens. Poult Sci. 2018;97(3):920–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Mayr GW, Thieleczek R. Masses of inositol phosphates in resting and tetanically stimulated vertebrate skeletal muscles. Biochem J. 1991;280(3):631–40. doi: 10.1042/bj2800631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Stephens LR, Downes CP. Product-precursor relationships amongst inositol polyphosphates. Biochem J. 1990;265:435–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Holub BJ. Metabolism and function of phospholipids. Annu Rev Nutr. 1986;(6):563–97. [DOI] [PubMed] [Google Scholar]
  • 44.Howard CF, Anderson L. Metabolism of myo-lnositol in animals. Arch Biochem Biophys. 1967;118(2):332–9. [DOI] [PubMed] [Google Scholar]
  • 45.Cupisti A, Kalantar-Zadeh K. Management of Natural and Added Dietary Phosphorus Burden in Kidney Disease HHS Public Access Author manuscript. Semin Nephrol. 2013;33(2):180–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Prasad N, Bhadauria D. Renal phosphate handling: Physiology. Indian J Endocrinol Metab. 2013;17(4):620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Martin A, Quarles LD. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis. Adv Exp Med Biol. 2012;728:126–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Michigami T, Kawai M, Yamazaki M, Ozono K. Phosphate as a signaling molecule and its sensing mechanism. Physiol Rev. 2018;98(4):2317–48. doi: 10.1152/physrev.00022.2017 [DOI] [PubMed] [Google Scholar]
  • 49.Segawa H, Yamanaka S, Ito M, Kuwahata M, Shono M, Yamamoto T, et al. Internalization of renal type IIc Na-Pi cotransporter in response to a high-phosphate diet. Am J Physiol—Ren Physiol. 2005;288(3 57–3):587–96. doi: 10.1152/ajprenal.00097.2004 [DOI] [PubMed] [Google Scholar]
  • 50.Ren Z, Piepenburg AJ, Yang X, Cook ME. Effect of anti-fibroblast growth factor 23 antibody on phosphate and calcium metabolism in adenine gavaged laying hens. Poult Sci. 2019;98(10):4896–900. doi: 10.3382/ps/pez239 [DOI] [PubMed] [Google Scholar]
  • 51.Horst RL, Littledike ET, Riley JL, Napoli JL. Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal Biochem. 1981;116:189–203. doi: 10.1016/0003-2697(81)90344-4 [DOI] [PubMed] [Google Scholar]
  • 52.Bar A, Sharvit M, Noff D, Edelstein S, Hurwitz S. Absorption and excretion of cholecalciferol and of 25-hydroxycholecalciferol and metabolites in birds. J Nutr. 1980. Oct 1;110(10):1930–4. doi: 10.1093/jn/110.10.1930 [DOI] [PubMed] [Google Scholar]
  • 53.Shanmugasundaram R, Selvaraj RK. Vitamin D-1α-hydroxylase and vitamin D-24-hydroxylase mRNA studies in chickens. Poult Sci. 2012;91(8):1819–24. doi: 10.3382/ps.2011-02129 [DOI] [PubMed] [Google Scholar]
  • 54.Warren MF, Livingston KA. Implications of vitamin D research in chickens can advance human nutrition and perspectives for the future. Curr Dev Nutr. 2021;5(5):1–17. doi: 10.1093/cdn/nzab018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Warren MF, Vu TC, Toomer OT, Fernandez JD, Livingston KA. Efficacy of 1-α-hydroxycholecalciferol supplementation in young broiler feed suggests reducing calcium levels at grower phase. Front Vet Sci. 2020;7(June):1–11. doi: 10.3389/fvets.2020.00245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Qian H, Kornegay ET, Denbow DM. Utilization of phytate phosphorus and calcium as influenced by microbial phytase, cholecalciferol, and the calcium:total phosphorus ratio in broiler diets. Poult Sci. 1997;76(1):37–46. doi: 10.1093/ps/76.1.37 [DOI] [PubMed] [Google Scholar]
  • 57.Shafey TM, McDonald MW, Pym RAE. Effects of dietary calcium, available phosphorus and vitamin d on growth rate, food utilisation, plasma and bone constituents and calcium and phosphorus retention of commercial broiler strains. Br Poult Sci. 1990;31(3):587–602. doi: 10.1080/00071669008417290 [DOI] [PubMed] [Google Scholar]
  • 58.Mohammed A, Gibney MJ, Taylor TG. The effects of dietary levels of inorganic phosphorus, calcium and cholecalciferol on the digestibility of phytate-P by the chick. Br J Nutr. 1991;66(2):251–9. doi: 10.1079/bjn19910029 [DOI] [PubMed] [Google Scholar]
  • 59.Edwards HM, Elliot MA, Sooncharernying S, Britton WM. Quantitative requirement for cholecalciferol in the absence of ultraviolet light. Poult Sci. 1994;73(2):288–94. doi: 10.3382/ps.0730288 [DOI] [PubMed] [Google Scholar]
  • 60.Taylor TG, Moore JH. The effect of high and low levels of dietary inorganic phosphate on the pre-laying storage of calcium and phosphorus and on the composition of the medullary and cortical bone in pullets. Br J Nutr. 1958;12(1):35–42. doi: 10.1079/bjn19580007 [DOI] [PubMed] [Google Scholar]
  • 61.Taylor TG, Moore JH. Avian Medullary Bone. Nature. 1953;172:812–4. [Google Scholar]
  • 62.Moritoh Y, Abe S, Akiyama H, Kobayashi A, Hara R, Kasai S, et al. Kinase controls circulating phosphate in mammals. Nat Commun. (2021):1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Juan J Loor

27 Apr 2022

PONE-D-22-04744Phytase dose-dependent response of kidney inositol phosphate levels in poultryPLOS ONE

Dear Dr. Brearley,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I CONCUR WITH ALL THE COMMENTS RAISED BY THE THREE REVIEWERS. PLEASE ADDRESS THESE ISSUES IN THE REVISED MANUSCRIPT.

Please submit your revised manuscript by Jun 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide additional information on the animal research and ensure you have included details on : (1) methods of sacrifice (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering.

3.In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Sprigg et al Phytase dose-dependent response of kidney inositol phosphate levels in poultry

Phytase is one of the most used feed additives in animal nutrition, with benefits ranging from animal productivity, reduction of feed costs, reduced environmental impact. This work extends these benefits by study the impact at metabolic level generation of inositol phosphates in different parts of the gastro-intestinal tract, specifically exploring the role of phytase in release inositol phosphate in tissues. The authors provided clarity the data described here is part of a larger project to be published elsewhere.

L23, please delete one bracket; clarify what is meant by “larger 2x4 design.

L93-94; though not part of this study it would be informative to clarify why two levels of titanium were investigated

L100 (Table 1), are you certain the table displays analyzed or calculated nutrient? If analyzed describe how AME and NE were analyzed? Please note should be Crude fat not Fat. What does soy oil global mean? Is available P and Ca account for phytase contribution?

L107, please clarify declared crude protein

L114-115; previously indicated there two levels of titanium? Please clarify?

L117, please clarify the reason behind this does of inositol?

L118, italicize E. coli

L124/Table 2; please provide clear description of the diets, for example what is the difference between Control vs. control Ti, reader should be able to understand the table without referring to the text. Besides this why would you expect inositol concentrations to vary between Ti and non-Ti diets; variation is appreciable and the best way to present the data is mean±SD

L142, how were 6 replicates arrived at, was power analyses conducted to justify these number of replications?

L162-163, please add information on how the organs were processed prior to aliquoting 100 mg for analyses; ideally one would expect the whole organ homogenized and sub-sample taken

L166; should be mL not ml, please updated throughout the manuscript

L275; please explain this concept “The use of TiO2 as a pre-concentration method for inositol phosphates” also in relation of why data in Table 5 is not presented as diets with and without Ti

Reviewer #2: The manuscript is part of a study performed to investigate the impact of microbial phytase (0, 500 and 6000 FTU/kg) and inositol phosphate in the presence or absence of TiO2 on InsPx profiles in the gizzard and ileum digesta as well as in the kidney and liver of broilers. The major InsPx isomers found in the gizzard and ileum digesta were different from those in the liver and kidney, hence it was concluded that the InsPx in the kidney and liver was not directly absorbed from the digestive tract but synthesized de novo. This conclusion did not seem to be very well supported by the findings, because 1). It was unknown from this manuscript if InsPx isomers could be directly absorbed from the intestine or not, if so which transporters involved; 2). It could not be excluded that the intestine selectively absorbed some InsPx isomers and then directly deposit them in the kidney, resulting in the different InsPx isomers found in the kidney/live from those in the gizzard and ileum digesta. Next to that, experimental design and statistical analysis of the complete study were described, while only three treatments were selected for InsPx analysis. Please remove all treatments/tissues that were not used in this study. Lastly, there are many typo mistakes in the current manuscript, particularly in the tables.

Line 25: Only the kidney and liver tissues of three treatments were analyzed.

Line 28-33. The IP esters found in the tissue is different from those in the digesta, while the conclusion was not well supported. See comments above.

Line 109: what is Mb? Mg?

Line 114-122: Design of the whole study was described, while only three treatments were selected for analysis. Please only describe the treatments/tissues that were used in the analysis, to be consistent with the treatment groups shown in tables/results.

Line 124. InsP3 of the Phy6000 Ti group was much lower than other treatments, suggesting a lab mistake? By the way, this should be the measured inositol phosphate concentration in all treatment diets, not the basal diets.

Line 140 and 143. typo mistake, conflicting starting days, day 0 in line 140 and day 1 in line 143.

Line 158-162. Please only describe the tissues used for inositol phosphate analysis.

Please clarify how were the gizzard and ileum content collected?

Line 190-193: do not understand the eluting procedure.

Line 203-207. Please describe the statistical analysis used in this study, not the whole study because only three treatments were selected for analysis.

Line 228, Table 3: Why was the total InsP reduced with phytase inclusion in the gizzard? Could any of these InsPx or inositol be absorbed from the gizzard, if so, which transporter(s) involved?

Please add P values to the table.

Typo mistake, 0.188c

Line 236-238. data analysis description did not agree with the table 3-6.

Line 271-277. Already described in the materials and methods section.

Line 280. Table 5. several typo mistakes, 12.57a,,,,3.0ab

Please check the numbers and superscripts in the table

Line 298. typo mistake. Double ..

Line 295-296. significance was not shown with superscript letter in table 5.

Line 298-300. compared to the control group or the Phy6000 group?

Line 338, typo mistake, day 21.

Line 394-425. This part was actually more about whole body Ca and P homeostasis. It is a pity that a connection between Ca and P homeostasis and tissue InsPx metabolism was missing.

Maybe add a short paragraph to summarize the major findings and conclusions.

Reviewer #3: In this manuscript, the authors investigated the effect of phytase on the inositol/phosphate in gizzard, ileum, kidney, liver, and other tissues. The results are interesting, but the manuscript writing and data presentation are confusing and difficult to follow. The following are the specific concerns.

1. At line 93, what are the “2 x 4 factorial arrangement”? What are the 2 factors? And what are the 4 levels?

2. At lines 94-5, what are the “Two basal diets (Table 1)”? I only saw one diet.

3. At lines 114-122 and table 2, it is confusing, what were the dietary treatments? The dietary description made more confusing. Looks like 8 diets, based on Table 2. Please make a dietary table.

4. In the tables of inositol/phosphate, please use only one unit, either micro or nano mole. It is very confusing to switch the unit back and forth. In table 2, please summarize the total inositol/phosphate, just as in other tables. Are the values significant different between diets?

5. For the data in tables 3, 4, 5, and 6, it would be useful to compare the relative values of the digesta/tissue inositol/phosphate to the dietary levels, at least for the total values. The absolute values would be easily misinterpreted if without dietary values.

6. Please remove the subtitle in discussion sections and the discussion should be concise and focus on new findings and implications.

7. Please move Figure 1 to result section.

8. Please provide background information about what means for the inositol and InsP3-6 in the context of phytase? More phytase, more inositol in digesta and/or tissue?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Elijah G. Kiarie

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 19;17(10):e0275742. doi: 10.1371/journal.pone.0275742.r002

Author response to Decision Letter 0


16 Jun 2022

To whom it may concern,

Re. Phytase dose-dependent response of kidney inositol phosphate levels in poultry

Authors: Colleen Sprigg1, Hayley Whitfield1, Emily Burton2, Dawn Scholey2, Michael R. Bedford3, Charles A. Brearley1*

On behalf of all authors, I am pleased to return a revised manuscript that addresses the considered criticisms of our manuscript. We thank the reviewers and the editor for their inputs.

Our revisions address points raised by the Academic Editor:

1. We have edited our manuscript to meet PLOS ONE’s style requirements

2. Method of sacrifice, anaesthesia and efforts to alleviate suffering statement are provided in the text, new lines 128-149.

We additionally note:

The study was conducted feeding test materials previously investigated in a number of broiler studies and shown to cause no pain, suffering or lasting harm. The birds were not exposed to invasive experimental procedures during the study and received routine care and husbandry akin to a commercial broiler farm. No analgesia / anaesthetic was required, and no suffering occurred prior to death. The study was overseen by the site Named Animal Care and Welfare Officer, who is empowered to end the trial immediately if they believe any suffering occurs. Birds were health checked twice daily by a technical team not involved in the outcome of the study, and any sick or lame birds were euthanised immediately. A record table was used throughout the study to assure no deaths or illness were associated with any treatment and that mortality did not rise above the expected level for the age and strain of bird.

3. We have provided the raw data as excel files (Supporting Information)

To address the points raised by Reviewer #1:

L23 and L93-94: we have modified the description of the experimental design to emphasize the comparisons for which data is provided in this manuscript (new lines 22-23 and 92-95). Our reference to the use of titanium is limited to new lines 128-130.

L100: Table 1 has been corrected to include statement of calculated value, rather than measured; Crude fat and a clarifying footnote 3 states that Available phosphate does not account for the contribution of phytate P.

L107: the crude protein content is clarified as footnote 1

L114-115: is addressed in response to L93-94 above

L117: reference to inositol dose has been removed from the manuscript, because we restrict our analysis of effect of phytase dose. But, for our reviewer: in a typical diet there are approximately 2-2.5g of inositol per kg feed in the form of IP6 so if this were totally dephosphorylated through superdosing of phytase it would yield approximately 2-2.5g inositol

L118: corrected

L124: again (see L117, reference to treatments not discussed in this manuscript (inositol and titanium) have been removed. This accommodates the concerns of Reviewers #2 and #3.

L142: we provide below (not in the text) a statement of our power calculations.

Data for mean gizzard and ileal inositol contents in responses to phytase additional with N and standard error reported by Walk et al., 2018 was used to conduct a power calculation indicating 6 replicates per treatment were sufficient to identify treatment differences at a power setting of 80% and a type 1 error rate of 5%.

https://www.sciencedirect.com/science/article/pii/S0032579119309800

Walk, C.L., Bedford, M.R. and Olukosi, OA. (2018) Effect of phytase on growth performance, phytate degradation and gene expression of myo-inositol transporters in the small intestine, liver and kidney of 21 day old broilers. Poultry Science 97(4) 1155-1162

L162-163: Tissue was sub-sampled from frozen organs, rather than extraction of the entire organ (new line 171). This approach was taken to allow trial development of methods appropriate for other classes of analyte not described in this study.

L166: corrected.

L275: while researchers have noted empirical difference in eg. Ileal digestibility with different digestibility markers, it has not been appreciated by the animal nutrition field that that cell biology/signalling community have adopted the use of titanium dioxide as a solid phase extraction media for inositol phosphates. Indeed, we had cited the relevant methods (here in new lines 178-184 [32]). We will return to the discussion of the suitability of TiO2 as a digestibility marker, for inositol phosphate analysis in digesta and tissues in a subsequent manuscript. But, to simplify this manuscript, for the reader, in line with the preferences of Reviewers #2 and #3, we have limited our discussion in the revised manuscript to 3 treatments only (control, 500 and 6000FTU/kg ). We hope this ‘compromise’ meets the needs of all our reviewers.

To address the points raised by Reviewer #2:

1) and 2) we provide a more detailed explanation of inositol hexakisphosphate synthesis and inositol hexakisphosphate degradation by phytases (new lines 378-389) that argues at which point in metabolic sequences the diagnostic 2-phosphate is added or removed. The alternative, that inositol phosphates are taken up intact from the gut, cannot be discounted (and we say as much, new lines 382-383) but such a premise would necessarily be an invention since gut inositol phosphate transporters have not been described. Philosophically, the simplest explanation is the best – until transporters are identified.

2) We have removed all reference to treatments of the experimental design, for which data is not analysed.

We have corrected the assorted typos.

Line 25: we have corrected the sentence (new lines 25-26)

Lines 28-33: now addressed (see response to 1 and 2, above (new lines 378-389). We hope we have emphasized how isomeric identity (the 2-phosphate) is key to a full-understanding of the origins of isomers in tissues. A seminal reference [42] is cited (new line 378) to support the argument.

Line 109: corrected to Magnesium (new line 108)

Lines 114-122: we have amended the text to discuss the three treatments only (new lines 115-121).

Line 124: the titanium-containing diets have been removed from the analysis as requested (2) and Lines 114-122). We provide values of different IPs for the three diets in Table 2.

Lines 140 and 143, corrected

Lines 158-162: we have provided new details (new lines 153-169).

Lines 190-193: All details of our use of TiO2 beads to pre-concentrate and elute inositol phosphate (after Wilson et al [32]) are provided (new lines 178-192). In short, inositol phosphates bound to TiO2 under acid conditions can be eluted by change to alkaline pH.

Lines 203-207: the details of our statistical analyses (limited to Control, Phy500 and Phy6000 treatments) are provided (new lines 85-86 and 210-214).

Line 228: we, and others, have observed that soluble IPs transit through the GI tract faster than the insoluble marker and comment on this (new lines 275-279). We note that inositol transporters have been most widely studied in the small intestine of poultry and that inositol phosphate transporters have not been described (see also 1) and 2), above).

P values have been added to the table.

Lines 236-238: now corrected

Lines 271-277: text removed

Line 280: the Table has been corrected

Line 298: typo corrected.

Lines 295-296: corrected

Lines 298-300: full details of the comparisons made are provided (as probabilities) in Table 3

Line 338: corrected

Lines 394-425: we agree with the sentiment but the literature is sparse. Consequently, we leave our discussion of the topic to (new lines 455-561). We remain convinced that our data and this manuscript will encourage cell biologists to look at the poultry nutrition literature and the animal nutritionists to look at the cell biology of inositol phosphates.

A short paragraph: we hope the concluding sentences (new lines 455-461) make the point.

To address the points raised by Reviewer #3:

1.Line 93: we have now limited the statistical analysis to the three treatments Control, Phy500 and Phy6000 and removed confusing reference to other aspects of the feeding trial that are not reported here. This satisifies Reviewer #2 (Lines 114-122, 124). We retain mention of digestibility marker but emphasize it is not discussed further.

2. Lines 94-5: as above

3. Lines 114-122: now described (new lines 128-130 and made evident in Table 2)

4.: Table 2 is provided, we make no claim of significant difference

5.: Tables 3,4,5,6, now include summed inositol phosphates, all reported in the same unit

6.: Subtitles have been removed, the discussion remains largely the same.

7.: Figure 1 has been moved

8.: Table 4 and Table 5 and the associated description (new lines 266-279) makes the point that as phytase dose increases and inositol phosphates are reduced in the gizzard and ileal digesta so the gizzard and ileal inositol increases. This is consistent with the literature (new lines 285 and 398, references [9,20,27] and [9,16,17,23-27], respectively.

We thank our reviewers for their helpful comments on our manuscript.

Yours faithfully

Charles Brearley

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Juan J Loor

22 Aug 2022

PONE-D-22-04744R1Phytase dose-dependent response of kidney inositol phosphate levels in poultryPLOS ONE

Dear Dr. Brearley,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

PLEASE ADDRESS THE FINAL COMMENTS. I WILL MAKE A FINAL DECISION AFTERWARDS.

Please submit your revised manuscript by Oct 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #4: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #4: Partly

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #4: 1 Abstract was not associated with the results, especially L27-29. There was no linear or quadratic analysis in the statistical analysis part. At the same time, no P value of liner relationship was shown in results table.

2 How many birds were used in this study? The number was not correct.

3 In introduction, the hypothesis of this study was not clear. From L67 to L80, these parts had no strong relationship with the object of the study.

4 L85 what kind of design? 2*4 or 3 treatments? So many statements of experiment design were not consistent.

5 there was no direct results of plasma vitamin D content in this study. L475-L482 the discussion of vitamin D metabolism in chicken was not suitable with less logic.

6 L494-L503 which results was discussed in this paragraph? Many references mentioned mRNA expressions during calcium and phosphate metabolism, what’s the relationship with the results?

7 in conclusion part, this study suggested that TiO2 was a better preconcentration of method for inositol phosphate analysis, but less discussion was mentioned. Thus, the conclusion of this study need rewrite.

Reviewer #5: I believe the authors have addressed all the comments adequately, and I have no further comments as a reviewer reviewed the respsonses of the authors to the other reviewers' comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #4: No

Reviewer #5: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Oct 19;17(10):e0275742. doi: 10.1371/journal.pone.0275742.r004

Author response to Decision Letter 1


26 Aug 2022

PONE-D-22-04744R1

Phytase dose-dependent response of kidney inositol phosphate levels in poultry

PLOS ONE

To The Editor,

We thank our reviewers for their consideration of our manuscript and the opportunity afforded to improve the manuscript further. We hereby respond to the comments of Reviewer #4:

1. Abstract was not associated with the results, especially L27-29.

We think the reviewer has not appreciated that L27-29 make reference to the results described in lines 374-382: paragraph beginning, ‘ The peaks identified in Fig 1B…’ and further elaborated in the Discussion, paragraphs 1 and 2, lines 386-411.

There was no linear or quadratic analysis in the statistical analysis part. At the same time, no P value of liner relationship was shown in results table.

The reviewer is correct, testing makes clear that the relationship is non-linear, we have therefore removed references to linearity – changing the term to one ‘progressive’- that does not need statistical validation.

2. How many birds were used in this study? The number was not correct. The trial as a whole was a 2 x 4 factorial design, of 8 treatments, designed to test 3 separate hypotheses. Data presented in this study speaks to only 3 of these treatment groups, with 60 birds per treatment in 6 pens of 10 birds per pen, totalling 180 birds.

This has been further clarified in lines 146-149.

3. In introduction, the hypothesis of this study was not clear. From L67 to L80, these parts had no strong relationship with the object of the study.

We have clarified this by addition of a sentence, lines 81-83, beginning, ‘It was hypothesised that ….’.

4. L85 what kind of design? 2*4 or 3 treatments? So many statements of experiment design were not consistent.

This has been further clarified in lines 146 to 149

5. there was no direct results of plasma vitamin D content in this study. L475-L482 the discussion of vitamin D metabolism in chicken was not suitable with less logic.

We choose to retain the Discussion unaltered and make the point that the Discussion puts our results in context of calcium and phosphate homeostasis and inter-organ axis for its control. Put simply, we are the first to describe effect of phytase on the inositol phosphates of any tissue, let alone kidney. That the kidney is central to phosphate and calcium homeostasis deserves the discussion of how the kidney is involved in calcium and phosphate homeostasis. We do believe that the assorted readers of this manuscript will hold a range of perspectives that make our Discussion relevant to their interests.

6. L494-L503 which results was discussed in this paragraph? Many references mentioned mRNA expressions during calcium and phosphate metabolism

We think the reviewer has not appreciated that Discussion, paragraph 7 specifies a study (Greene et al. (15)) that describes effects of phytase on inositol phosphate synthesis genes. These genes should influence inositol phosphate levels and our study measures inositol phosphates in tissues.

what’s the relationship with the results?

Discussion, paragraphs 2 and 3, explicitly places the observed results for kidney inositol phosphate changes in the context of phosphate homeostasis under the prevailing sufficient phosphate and calcium provision conditions of this study.

7. in conclusion part, this study suggested that TiO2 was a better preconcentration of method for inositol phosphate analysis, but less discussion was mentioned. Thus, the conclusion of this study need rewrite.

We have expanded the last sentence of the last paragraph of Discussion, but retain the focus on the results that this method reveals (rather than the method itself, which we properly report as having been published previously by Wilson et al. 2015, but which has not been used for tissue/organ purpose).

Finally, we reiterate the comments of Reviewer #5: I believe the authors have addressed all the comments adequately, and I have no further comments as a reviewer reviewed the respsonses of the authors to the other reviewers' comments.

Yours faithfully

Charles Brearley

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Juan J Loor

22 Sep 2022

Phytase dose-dependent response of kidney inositol phosphate levels in poultry

PONE-D-22-04744R2

Dear Dr. Brearley,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Juan J Loor

10 Oct 2022

PONE-D-22-04744R2

Phytase dose-dependent response of kidney inositol phosphate levels in poultry

Dear Dr. Brearley:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Juan J Loor

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (ZIP)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files. Any question pertaining to the data underlying the results presented in the study can be addressed to Charles Brearley, University of East Anglia.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES